On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q2 2023 earnings per share (EPS) of -$0.54, up 11.48% year over year. Total Acasti Pharma earnings for the quarter were -$4.02 million. In the same quarter last year, Acasti Pharma's earnings per share (EPS) was -$0.61.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.